share_log

Camp4 Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Michael P. Rubin(11.5%),Northpond Ventures II, LP(5.1%), etc.

SEC ·  Oct 23, 2024 06:53
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more